CD4 and cancer: The immune cells analyzed included CD8+ T cells, CD4+ T cells, B cells, tumor-associated macrophages (TAMs), monocytes, M1 and M2 macrophages, cancer-associated fibroblasts (CAFs), myeloid-derived suppressor cells (MDSCs), neutrophils, DCs, and natural killer (NK) cells.